Martin Backer
No Rating Available
(Learn About Our Rating System)

Martin Backer, MD, FAAP

Languages spoken: English, French, German, Spanish

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-585-2031
Directions

University of Utah Hospital

Infectious Diseases, Area E
Salt Lake City
801-585-2031
Directions

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Infectious Disease)
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Infectious Diseases
    Infectious Diseases
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Infectious Disease)
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

    Education history

    Fellowship Combined Adult & Pediatric Infectious Diseases - SUNY Downstate Health Sciences University, Medical Center Fellow
    Residency Combined Internal Medicine-Pediatrics - Maimonides Medical Center Resident
    Professional Medical Medicine - Faculty of Medicine, University of Buenos Aires M.D.

    Selected Publications

    Journal Article

    1. Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, Kublin JG, Huang Y, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Goepfert PA, Walsh SR, Follmann D, Kotloff KL, NIAID-funded COVID-19 Prevention Network CoVPN (2023). Risk of COVID-19 after natural infection or vaccination. EBioMedicine, 96, 104799. (Read full article)
    2. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Treli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH, COVAIL Study Group (2023). Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med, 29(9), 2334-2346. (Read full article)
    3. Lyke KE, Atmar RL, Dominguez Islas C, Posavad CM, Deming ME, Branche AR, Johnston C, El Sahly HM, Edupuganti S, Mulligan MJ, Jackson LA, Rupp RE, Rostad CA, Coler RN, Bcker M, Kottkamp AC, Babu TM, Dobrzynski D, Martin JM, Brady RC, Frenck RW Jr, Rajakumar K, Kotloff K, Rouphael N, Szydlo D, PaulChoudhury R, Archer JI, Crandon S, Ingersoll B, Eaton A, Brown ER, McElrath MJ, Neuzil KM, Stephens DS, Post DJ, Lin BC, Serebryannyy L, Beigel JH, Montefiori DC, Roberts PC, DMID 21-0012 Study Group (2023). Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. NPJ Vaccines, 8(1), 98. (Read full article)
    4. Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH (2023). Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. (Read full article)
    5. Scherer EM, Backer M, Carvajal K, Danziger-Isakov L, Frey S, Howard LM, Scaggs Huang F, Kottkamp AC, Reid T, Rodriguez-Barradas MC, Stankiewicz Karita HC, Teoh Z, Wald A, Whitaker J, Wiley Z, Ofotokun I, Edwards KM, Infectious Diseases Clinical Research Consortium IDCRC Mentorship Program Writing Group (2022). The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action. Clin Infect Dis, 76(4), 753-759. (Read full article)
    6. Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC, DMID 21-0012 Study Group (2022). Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Rep Med, 3(7), 100679. (Read full article)
    7. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Rostad CA, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Treli S, Makhene M, Crandon S, Lee M, Nayak SU, Montefiori DC, Makowski M, Smith DJ, Roberts PC, Beigel JH, COVAIL Study Group (2022). SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. (Read full article)
    8. Noor A, Backer M, Krilov LR (2022). Children Lagging with COVID-19 Vaccination. Pediatr Ann, 51(5), e180-e185. (Read full article)
    9. Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, OConnell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH, DMID 21-0012 Study Group (2022). Homologous and Heterologous Covid-19 Booster Vaccinations. N Engl J Med, 386(11), 1046-1057. (Read full article)
    10. Ulrich RJ, Troxel AB, Carmody E, Eapen J, Bcker M, DeHovitz JA, Prasad PJ, Li Y, Delgado C, Jrada M, Robbins GA, Henderson B, Hrycko A, Delpachitra D, Raabe V, Austrian JS, Dubrovskaya Y, Mulligan MJ (2020). Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients. Open Forum Infect Dis, 7(10), ofaa446. (Read full article)
    11. Chotikanatis K, Suman N, Bcker M, Paudyal B, Schoeneman M, Kohlhoff S, Hammerschlag MR (2014). Pediatric Fistula Initiative: Reducing Bloodstream Infections in an Outpatient Pediatric Hemodialysis Center. J Pediatric Infect Dis Soc, 4(4), 363-6. (Read full article)
    12. Zhang X, Wallace O, Wright KJ, Backer M, Coleman JW, Koehnke R, Frenk E, Domi A, Chiuchiolo MJ, DeStefano J, Narpala S, Powell R, Morrow G, Boggiano C, Zamb TJ, Richter King C, Parks CL (2013). Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector. Virology, 446(1-2), 25-36. (Read full article)
    13. Landman D, Babu E, Shah N, Kelly P, Olawole O, Bcker M, Bratu S, Quale J (2012). Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother, 67(6), 1427-31. (Read full article)
    14. Quale J, Shah N, Kelly P, Babu E, Backer M, Rosas-Garcia G, Salamera J, George A, Bratu S, Landman D (2011). Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City. Microb Drug Resist, 18(2), 132-6. (Read full article)
    15. Chotikanatis K, Bcker M, Rosas-Garcia G, Hammerschlag MR (2011). Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient. J Clin Microbiol, 49(9), 3418-21. (Read full article)
    16. Landman D, Kelly P, Bcker M, Babu E, Shah N, Bratu S, Quale J (2010). Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother, 66(2), 332-4. (Read full article)
    17. Landman D, Urban C, Bcker M, Kelly P, Shah N, Babu E, Bratu S, Quale J (2010). Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. J Clin Microbiol, 48(12), 4604-7. (Read full article)
    18. Landman D, Babu E, Shah N, Kelly P, Bcker M, Bratu S, Quale J (2010). Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City. J Antimicrob Chemother, 65(10), 2123-7. (Read full article)

    Review

    1. Sidhu G, Delury J, Sanmugarajah J, Axiotis C, Backer M, Braverman AS (2009). Response of human immunodeficiency virus lymphomas to highly active anti-retroviral therapy without chemotherapy: report of four patients and literature review. [Review]. Leuk Lymphoma, 50(12), 2098-100. (Read full article)